Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
One World Products, Inc. (OWPC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/01/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/07/2022 |
8-K
| Appointed a new director|
Docs:
|
"SCHEDULES",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of September 1, 2022, is entered into by and between One World Products, Inc., a Nevada corporation, , and Tysadco Partners, LLC, a Delaware limited liability company . A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended . B. Upon the terms and conditions stated in this Agreement, the Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement on the date hereof , one hundred fifty thousand worth of restricted Series B...",
"TO REGISTRATION RIGHTS AGREEMENT" |
|
| 08/04/2022 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 02/18/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/30/2021 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Interactive Data |
| 09/27/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"PROMISSORY NOTE",
"COMMON STOCK PURCHASE WARRANT ONE WORLD PHARMA, INC. Warrant Shares: 1,500,000 Date of Issuance: September 24, 2021 This COMMON STOCK PURCHASE WARRANT certifies that, for value received of even date) , AJB Capital Investments, LLC, a Delaware limited liability company , is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from One World Pharma Inc. Inc., a Nevada corporation , up to 1,500,000 shares of Common Stock at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 24, 2021, by and among the Company and the Holder . Capitalized terms...",
"COMMON STOCK PURCHASE WARRANT ONE WORLD PHARMA, INC. Warrant Shares: 2,000,000 Date of Issuance: September 24, 2021 This COMMON STOCK PURCHASE WARRANT certifies that, for value received of even date) , AJB Capital Investments, LLC, a Delaware limited liability company , is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from One World Pharma Inc. Inc., a Nevada corporation , up to 2,000,000 shares of Common Stock at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated September 24, 2021, by and among the Company and the Holder . Capitalized terms...",
"SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of September 24, 2021, by and between ONE WORLD PHARMA, INC., a Nevada corporation, with headquarters located at 3471 W. Oquendo Road, Suite 301, Las Vegas, NV 89118 , and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 . WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth i...",
"SECURITY AGREEMENT" |
|
| 06/03/2021 |
8-K
| Quarterly results |
| 02/08/2021 |
8-K
| Quarterly results |
| 01/25/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 06/09/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/15/2020 |
8-K
| Other Events |
| 05/08/2020 |
8-K
| Quarterly results |
| 03/30/2020 |
8-K
| Quarterly results |
| 02/25/2020 |
8-K
| Quarterly results |
| 12/10/2019 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Share Purchase Agreement between OWP Ventures, Inc., Engineering Consulting S.A.S. and Lina María Isaza Díaz",
"Colombia’ s FEDECORE and One World Pharma Join Forces to Develop Large Scale Hemp Projects Benefitting Small Farmers Joint Venture Expected to Provide Significant Revenue Opportunities & Aligns With Company’ s Humanitarian Efforts LAS VEGAS, NV – One World Pharma Inc. , “OWP,” a fully licensed pure-play cannabis and hemp ingredient producer in Colombia, announced today that it has partnered with Colombia’ s FEDECORE to provide seed-to-sale assistance to qualified local populations in Colombia. FEDECORE is the ‘Colombian Federation of Regional Advisors,’ which defends human rights, promoting inclusive policies, programs, and projects. It is tasked with developing social projects in post-conflict, underdeveloped and struggling municipalities of Colombia to improve the quality of living..." |
|
| 07/12/2019 |
8-K/A
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...|
Docs:
|
"OWP VENTURES, INC. AUDITED FINANCIAL STATEMENTS For the Year Ended December 31, 2018",
"One World Pharma, Inc. and OWP Ventures, Inc. Pro Forma Financial Information For the Year Ended On February 21, 2019, One World Pharma, Inc. entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. , which is the parent company of One World Pharma, SAS . Pursuant to the Merger Agreement, we acquired OWP Ventures by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary . As a result of the Merger holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 shares of our common stock; options to purchase 825,000 shares of common stock of OWP Ventures at an exercise price of $0.50 automatically converte..." |
|
| 06/13/2019 |
8-K/A
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia... |
| 02/25/2019 |
8-K
| Quarterly results |
| 01/08/2019 |
8-K
| Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea... |
| 12/06/2018 |
8-K
| Entry into a Material Definitive Agreement, Changes in Control of Registrant, Departure of Directors or Certain Officers; Ele... |
| 02/18/2016 |
8-K
| Quarterly results |
| 01/12/2016 |
8-K
| Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain O... |
|
|